Sign in

CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
  1. 144 Insider Sale of Securities
  2. 4 Planned sale Chief Executive Officer sold 15,000 shares at an average $18.82 ($282,366)
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. 4 Planned sale President and COO sold 12,500 shares at $19.66 ($245,714)
  7. 144 Insider Sale of Securities
  8. 4 Planned sale Chief Executive Officer sold 36,766 shares at $19.17 ($704,657)
  9. 144 Insider Sale of Securities
  10. 4 Planned sale Chief Executive Officer sold 8,234 shares at an average $18.74 ($154,325)
  11. 144 Insider Sale of Securities
  12. 4 Planned sale President and COO sold 17,392 shares at $18.16 ($315,893)
  13. 4 Planned sale Chief Financial Officer sold 16,518 shares at an average $18.22 ($300,971)
  14. 4 Planned sale Chief Medical Officer sold 16,500 shares at an average $18.52 ($305,610)
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 5 of 14 · 266 filings